首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Pregnancy outcomes decline in recipients over age 44: An analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology
【24h】

Pregnancy outcomes decline in recipients over age 44: An analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology

机译:44岁以上接受者的妊娠结局下降:辅助生殖技术协会对27,959例新鲜供体卵体外受精周期的分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To use a large and recent national registry to provide an updated report on the effect of recipient age on the outcome of donor oocyte in vitro fertilization (IVF) cycles. Design Retrospective cohort study. Setting United States national registry for assisted reproductive technology. Patient(s) Recipients of donor oocyte treatment cycles between 2008 and 2010, with cycles segregated into five age cohorts: ≤34, 35 to 39, 40 to 44, 45 to 49, and ≥50 years. Intervention(s) None. Main Outcome Measure(s) Implantation, clinical pregnancy, live-birth, and miscarriage rates. Result(s) In donor oocyte IVF cycles, all age cohorts ≥39 years had similar rates of implantation, clinical pregnancy, and live birth when compared with the 40- to 44-year-old reference group. Patients in the two oldest age groups (45 to 49, ≥50 years) experienced statistically significantly lower rates of implantation, clinical pregnancy, and live birth compared with the reference group. Additionally, all outcomes in the ≥50-year-old group were statistically significantly worse than the 45- to 49-year-old group, demonstrating progressive decline with advancing age. Conclusion(s) Recent national registry data suggest that donor oocyte recipients have stable rates of pregnancy outcomes before age 45, after which there is a small but steady and significant decline.
机译:目的使用最新的大型国家注册中心提供有关接受者年龄对供体卵母细胞体外受精(IVF)周期结果影响的最新报告。设计回顾性队列研究。设置美国国家辅助生殖技术注册机构。 2008年至2010年间接受捐赠者卵母细胞治疗周期的患者,周期分为五个年龄段:≤34岁,35岁至39岁,40岁至44岁,45岁至49岁以及≥50岁。干预措施无。主要结果指标着床,临床妊娠,活产和流产率。结果在供体卵母细胞IVF周期中,与40至44岁的参考组相比,所有≥39岁的年龄组的着床率,临床妊娠率和活产率均相似。与参考组相比,两个最高年龄组(45至49岁,≥50岁)的患者的植入率,临床妊娠率和活产率均显着降低。此外,≥50岁组的所有结局在统计学上均显着低于45岁至49岁组,表明随着年龄的增长而逐渐下降。结论最近的国家注册数据表明,供卵母细胞接受者在45岁之前具有稳定的妊娠结局,此后下降很小但稳定且显着。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号